CEO Jeff Kraws Featured on Reuters' State of the Union Roundtable
This morning, Crystal Research's CEO Jeff Kraws was invited to participate in a roundtable discussion to ...
NEW RESEARCH: Quarterly Update on AtheroNova Inc.
Crystal Research Associates has released a Quarterly Update on AtheroNova Inc., a biotechnology company ...
NEW RESEARCH: New Year, Expanding Markets for LRAD Corp.
Yesterday we published a Quarterly Update on LRAD Corp. (LRAD-NASDAQ), a California-based company marketing ...
New Research: Report on MetaStat, Inc. (MTST-OTC.BB)
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on MetaStat, Inc.
Today, January 9, 2013 at 4 PM: "Fund Managers Unplugged"
If you are at the OneMedForum conference in San Francisco today, we invite you to join us for the “Special ...
"Special Session: Fund Managers Unplugged" at OneMedForum SF 2013
CEO Jeff Kraws selected to moderate a Special Session "Fund Managers Unplugged" at the 6th Annual OneMedForum ...
Happy Holidays from Crystal Research Associates
Season's Greetings! From all of us here at Crystal Research Associates, we would like to wish you and your ...
QUARTERLY UPDATE: AtheroNova (AHRO-OTC) Prepares for Phase I Trials
This morning, we issued a Quarterly Update on AtheroNova Inc. (AHRO-OTC.BB), a development-stage biotech ...
Crystal Research Associates to Sponsor 6th Annual OneMedForum
Partnership with OneMedPlace provides research and expanded media coverage to client companies
AtheroNova Completes $2.9 Million Private Placement of Common Stock
Biotech company AtheroNova Inc. (AHRO-OTC) this morning announced that it raised over $2.9 million in gross ...
New Nano Research: August 2012 Update Now Publicly Available
Crystal Research Associates' August 2012 nanotechnology update is now available here. This report is part of ...
EU: Finding a Regulatory Pathway for Nanomaterials
EU Commission Finds Existing Regulatory Framework to be Sufficient for Governing Nanomaterials